$3.920
-0.199 (-5.08%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による IMDX の予測・予想
Alphio's IMDX stock price prediction model matches the current Insight Molecular Diagnostics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.83 (-0.39%). The 1-week path is $3.97 (+3.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Insight Molecular Diagnostics Inc 株は買うべき?
Insight Molecular Diagnostics Inc (IMDX) appears to be a good buy right now due to its current price of $4.13, which is significantly below the analyst price target of $8, indicating a potential upside of 93.4%. Additionally, the company has a gross margin of 65.69% in Q2 2026, suggesting strong profitability potential as it scales. However, the main risk is the projected cash burn of approximately $8 million in the second half of 2026, which could impact financial stability if not managed effectively.
IMDX の株価は Monday に $3.92 で引け、その前に下落 -5.08%
Insight Molecular Diagnostics Inc (IMDX) last closed at $3.84, losing -2.04%. These facts feed the 1-day and 1-week IMDX price prediction above.
予想の要因
Insight Molecular Diagnostics Inc(IMDX)の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが IMDX に最も近い銘柄を、類似度順に表示します。
IMDX の季節性分析
Historically the probability of a positive September return for IMDX is 45.45%. October offers the highest probability of a positive month at 100.00%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。